Grodner Błażej, Napiórkowska Mariola
Chair and Department of Biochemistry and Pharmacogenomics, Medical University of Warsaw, 1 Banacha Str., 02-097 Warsaw, Poland.
Chair and Department of Biochemistry, Medical University of Warsaw, 1 Banacha Str., 02-097 Warsaw, Poland.
J Pharm Biomed Anal. 2017 Sep 5;143:285-290. doi: 10.1016/j.jpba.2017.05.043. Epub 2017 Jun 1.
The article describes the inhibitory effect of two new aminoalkanol derivatives on the enzymatic kinetic of tissue non-specific alkaline phosphatase with use of capillary zone electrophoresis to evaluate the inhibitory effect. This technique allows to investigate of the enzymatic kinetic by the measure of the amounts of the substrate and product in the presence of compound (I) or (II) in the reaction mixture. The separation process was conducted using an eCAP fused-silica capillary. The detector was set at 200nm. The best parameters for the analysis were: 25mM sodium dihydrogen phosphate adjusted to pH=2.5, temperature 25°C, and voltage -15kV. Lineweaver-Burk plots were constructed and determined by comparison of the Km, of alkaline phosphatase in the presence of inhibitor (I) or (II) with the Km in a solution without inhibitor. The influence of replacement the propylamine group by the dimethylamine group on tissue non-specific alkaline phosphatase inhibition activity of new derivatives (I) and (II) was investigated. The tested compounds (I) and (II) were found to be tissue non-specific alkaline phosphatase inhibitors. Detailed kinetic studies indicated a competitive mode of inhibition against tissue non-specific alkaline phosphatase for compound (I) and non-competitive mode of inhibition for compound (II).
本文描述了两种新型氨基烷醇衍生物对组织非特异性碱性磷酸酶酶动力学的抑制作用,并使用毛细管区带电泳来评估这种抑制作用。该技术通过测量反应混合物中存在化合物(I)或(II)时底物和产物的量来研究酶动力学。分离过程使用eCAP熔融石英毛细管进行。检测器设置在200nm。分析的最佳参数为:25mM磷酸二氢钠,pH值调至2.5,温度25°C,电压-15kV。通过比较存在抑制剂(I)或(II)时碱性磷酸酶的Km与无抑制剂溶液中的Km,构建并确定Lineweaver-Burk图。研究了用二甲胺基团取代丙胺基团对新衍生物(I)和(II)的组织非特异性碱性磷酸酶抑制活性的影响。测试的化合物(I)和(II)被发现是组织非特异性碱性磷酸酶抑制剂。详细的动力学研究表明,化合物(I)对组织非特异性碱性磷酸酶的抑制模式为竞争性,化合物(II)为非竞争性。